Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01445314 · ClinicalTrials.gov registry record
Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 598
- Enrollment target
NCT01445314: Completed study, sponsored by National Cancer Institute (NCI).
NCT01445314 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 598 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01445314 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 598 participants
- Enrollment target
Study Summary
Background: * People with chronic illness often are at risk for developing neurobehavioral problems due to effects of the disease or associated treatments. These problems may include cognitive impairments involving problem-solving, remembering things, paying attention, and understanding and using language, or emotional functioning or quality of life. * The National Cancer Institute Medical Illness Counseling Center Neuropsychology Group has collected data from neurobehavioral evaluations of infants, children, adolescents and adults with chronic illnesses enrolled in NIH protocols since 1987 and continues to collect data from patients enrolled in current protocols. * The data from these evaluations, along with demographic and medical information are stored in an NIH computer database. * Investigating the neurobehavioral functioning of patients with chronic illness is important for identifying and monitoring the effects of the disease and treatments over time, determining possible at-risk subgroups, evaluating response to therapy, and recommending educational and rehabilitative interventions. Objectives: -To learn about how certain illnesses or treatments may affect a person s cognitive abilities, emotional functioning and quality of life. Eligibility: * Patients currently enrolled in NIH studies who are having neuropsychological testing or completing quality-of-life questionnaires as part of that study. * Data obtained from infants, children, adolescents, and adults administered neurobehavioral assessments as part of a past or future NIH protocol. Design: * This study does not involve any extra tests or questionnaires; it uses information collected from evaluations that subjects have already completed or will complete as part of other NIH studies. * Information about participating patients that may help elucidate how cognitive abilities, emotional functioning, and quality of life are affected in people with chronic illness may be collected and stored.
Primary Outcome
describe neurobehavioural functioning based on stored data
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 598 participants |
| Start Date | 2007-03-23 |
| Est. Completion | 2024-08-08 |
What the finished NCT01445314 record still lists
NCT01445314 is an observational study that tracks outcomes without assigning an intervention. The registered 598 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01445314 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01445314 about?
NCT01445314 is a clinical study titled "Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments". Background: * People with chronic illness often are at risk for developing neurobehavioral problems due to effects of the disease or associated treatments. These problems may include cognitive impairments involving problem-solving, remembering things, paying attention, and understanding and using l...
What is the current status of trial NCT01445314?
This trial is currently completed. The enrollment target is 598 participants. The study started on 2007-03-23. Estimated completion is 2024-08-08.
Who is sponsoring clinical trial NCT01445314?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06875973 · 599 participants · Phase 3
Pelacarsen Roll-over Extension Program
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI